Varian Medical Systems (NYSE:VAR) is set to release its earnings data after the market closes on Wednesday, April 24th. Analysts expect Varian Medical Systems to post earnings of $1.16 per share for the quarter. Varian Medical Systems has set its FY 2019 guidance at $4.60-4.75 EPS and its FY19 guidance at $4.60-4.75 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.
Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, January 23rd. The medical equipment provider reported $1.06 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.07 by ($0.01). The company had revenue of $741.00 million for the quarter, compared to analysts’ expectations of $717.83 million. Varian Medical Systems had a return on equity of 26.18% and a net margin of 12.28%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.06 EPS. On average, analysts expect Varian Medical Systems to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
NYSE:VAR opened at $130.47 on Tuesday. The company has a market cap of $12.07 billion, a P/E ratio of 29.52, a P/E/G ratio of 3.46 and a beta of 0.86. Varian Medical Systems has a fifty-two week low of $101.42 and a fifty-two week high of $142.50.
A number of research firms recently weighed in on VAR. Zacks Investment Research raised shares of Varian Medical Systems from a “hold” rating to a “strong-buy” rating and set a $146.00 price objective for the company in a research report on Saturday, January 26th. Barrington Research reaffirmed a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, January 24th. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research report on Thursday, January 24th. Royal Bank of Canada raised their price target on shares of Varian Medical Systems to $130.00 and gave the company a “sector perform” rating in a research report on Thursday, January 24th. Finally, Jefferies Financial Group raised their price target on shares of Varian Medical Systems to $145.00 and gave the company a “buy” rating in a research report on Thursday, January 24th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $137.56.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.